Page last updated: 2024-08-24

naxagolide and Disease Models, Animal

naxagolide has been researched along with Disease Models, Animal in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	1 (50.00)	18.7374
1990's	1 (50.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bankiewicz, KS; Belluzzi, JD; Domino, EF; May, JM; McAfee, DA	1
de Yebenes, JG; Fahn, S; Jackson-Lewis, V; Mena, MA	1

Other Studies

2 other study(ies) available for naxagolide and Disease Models, Animal

Article	Year
N-0923, a selective dopamine D2 receptor agonist, is efficacious in rat and monkey models of Parkinson's disease. Movement disorders : official journal of the Movement Disorder Society, 1994, Volume: 9, Issue:2 Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Bromocriptine; Disease Models, Animal; Dominance, Cerebral; Dopamine Agents; Female; Injections, Intramuscular; Macaca nemestrina; Male; Oxazines; Oxidopamine; Parkinson Disease, Secondary; Prolactin; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D2; Stereotyped Behavior; Substantia Nigra; Tetrahydronaphthalenes; Thiophenes	1994
The effect of intracerebroventricular infusion of (+)-4-propyl-9-hydroxynapthoxacine (PHNO) through a totally implanted drug delivery system in rats with dopamine deficiency. Movement disorders : official journal of the Movement Disorder Society, 1987, Volume: 2, Issue:4 Topics: Animals; Brain; Corpus Striatum; Disease Models, Animal; Dopamine; Dopamine Agents; Infusion Pumps; Injections, Intraventricular; Male; Motor Activity; Neural Pathways; Oxazines; Parkinson Disease, Secondary; Rats; Rats, Inbred Strains; Receptors, Dopamine; Stereotyped Behavior; Substantia Nigra	1987

Article

Year

N-0923, a selective dopamine D2 receptor agonist, is efficacious in rat and monkey models of Parkinson's disease.

Movement disorders : official journal of the Movement Disorder Society, 1994, Volume: 9, Issue:2

Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Bromocriptine; Disease Models, Animal; Dominance, Cerebral; Dopamine Agents; Female; Injections, Intramuscular; Macaca nemestrina; Male; Oxazines; Oxidopamine; Parkinson Disease, Secondary; Prolactin; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D2; Stereotyped Behavior; Substantia Nigra; Tetrahydronaphthalenes; Thiophenes

1994

The effect of intracerebroventricular infusion of (+)-4-propyl-9-hydroxynapthoxacine (PHNO) through a totally implanted drug delivery system in rats with dopamine deficiency.

Movement disorders : official journal of the Movement Disorder Society, 1987, Volume: 2, Issue:4

Topics: Animals; Brain; Corpus Striatum; Disease Models, Animal; Dopamine; Dopamine Agents; Infusion Pumps; Injections, Intraventricular; Male; Motor Activity; Neural Pathways; Oxazines; Parkinson Disease, Secondary; Rats; Rats, Inbred Strains; Receptors, Dopamine; Stereotyped Behavior; Substantia Nigra

1987